A personal loan can be used for just about anything. It is a loan made for any purpose not specifically defined or secured by a specific asset. Personal loans are usually made for general expense purposes.
There are several types of personal loans out there for borrowers. The two most commonly know are secured and unsecured personal loans.
This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II. It is a GMP requirement that manufacturers control the critical aspects of their particular operations through qualification and validation over the life cycle of the product and process. Any planned changes to the facilities, equipment, utilities and processes, which may affect the quality of the product, should be formally documented and the impact on the validated status or control strategy assessed. Computerised systems used for the manufacture of medicinal products should also be validated according to the requirements of Annex 11. The relevant concepts and guidance presented in ICH Q8, Q9, Q10 and Q11 should also be taken into account.
Highlights of the guidance are given in following presentation.
This presentation provides information on computerized system validation from the World Health Organization (WHO). It discusses the purpose and principles of validation to ensure performance of computer systems. Key points covered include validation protocols and reports, evaluating vendor systems, requirements specifications, functional specifications, and maintaining validated systems. The presentation is intended to provide pharmaceutical professionals with latest guidance on computerized system validation.
This document provides guidance on validation and qualification principles from the World Health Organization (WHO). It discusses the need for validation and qualification activities to ensure product quality, safety, and efficacy throughout the product lifecycle. Key aspects covered include definitions of validation terms, approaches to validation planning, and documentation requirements such as a validation master plan and protocols.
This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II. It is a GMP requirement that manufacturers control the critical aspects of their particular operations through qualification and validation over the life cycle of the product and process. Any planned changes to the facilities, equipment, utilities and processes, which may affect the quality of the product, should be formally documented and the impact on the validated status or control strategy assessed. Computerised systems used for the manufacture of medicinal products should also be validated according to the requirements of Annex 11. The relevant concepts and guidance presented in ICH Q8, Q9, Q10 and Q11 should also be taken into account.
Highlights of the guidance are given in following presentation.
This presentation provides information on computerized system validation from the World Health Organization (WHO). It discusses the purpose and principles of validation to ensure performance of computer systems. Key points covered include validation protocols and reports, evaluating vendor systems, requirements specifications, functional specifications, and maintaining validated systems. The presentation is intended to provide pharmaceutical professionals with latest guidance on computerized system validation.
This document provides guidance on validation and qualification principles from the World Health Organization (WHO). It discusses the need for validation and qualification activities to ensure product quality, safety, and efficacy throughout the product lifecycle. Key aspects covered include definitions of validation terms, approaches to validation planning, and documentation requirements such as a validation master plan and protocols.